King's Sarcoidosis Questionnaire (KSQ) - Validation study in Serbian speaking population of sarcoidosis patients
- PMID: 37669301
- PMCID: PMC10479938
- DOI: 10.1371/journal.pone.0273126
King's Sarcoidosis Questionnaire (KSQ) - Validation study in Serbian speaking population of sarcoidosis patients
Abstract
Introduction: Sarcoidosis is a multiorgan, multisystem chronic disease of unknown etiology and unpredictable course. Health status is reduced in sarcoidosis and assessing it is a difficult multitask effort due to many faces this disease might have. Recently, a new questionnaire for assessing health status in sarcoidosis was developed by a group of authors from England-King's Sarcoidosis Questionnaire (KSQ). The benefit of KSQ is the ability to develop the best care plan for the patient, as well as to differentiate the efficacy of the administered treatment.
Objective: The aim of this study was to validate the KSQ in Serbian speaking population of sarcoidosis patients. The test itself is a modular, multi-organ health status measure for patients with sarcoidosis for use in clinic and the evaluation of therapies. The correlation of KSQ with different clinical course of sarcoidosis (acute vs chronic disease) and with the clinical outcome status (COS) in sarcoidosis was also investigated.
Methods: A total of 159 biopsy positive sarcoidosis patients participated in this study. The average age of the participants was 49.67, majority was female (67.3%) and majority had only pulmonary form of sarcoidosis (71.7%). KSQ - new disease-specific health status instrument, was compared with 5 other already existing instruments already used and validated in sarcoidosis (Saint George Respiratory Questionnaire- SGRQ, Daily Activity List -DAL, Fatigue Assessment Scale- FAS, Medical Research Council dyspnea scale-MRC, Borg Dyspnea Scale and 15D as general questionnaire.
Results: KSQ has significant correlation with other quality of life questionnaires already used in sarcoidosis. Translated version of KSQ shows significant internal reliability, similar to the original KSQ. Serbian version of KSQ has significant correlation with different clinical course of sarcoidosis and with COS as well. The translated version of KSQ is reliable sarcoidosis specific instrument for assessing health status in these patients.
Copyright: © 2023 Stjepanovic et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Conflict of interest statement
The authors have declared that no competing interests exist.
Similar articles
-
Validation of the King's Sarcoidosis Questionnaire (KSQ) in a Dutch sarcoidosis population.Sarcoidosis Vasc Diffuse Lung Dis. 2016 Mar 29;33(1):75-82. Sarcoidosis Vasc Diffuse Lung Dis. 2016. PMID: 27055839
-
Translation and psychometric properties of the King's Sarcoidosis Questionnaire (KSQ) in German language.Health Qual Life Outcomes. 2019 Apr 11;17(1):62. doi: 10.1186/s12955-019-1131-z. Health Qual Life Outcomes. 2019. PMID: 30975148 Free PMC article.
-
Evaluating the Minimal Clinically Important Difference of the King's Sarcoidosis Questionnaire in a Multicenter Prospective Study.Ann Am Thorac Soc. 2021 Mar;18(3):477-485. doi: 10.1513/AnnalsATS.202006-607OC. Ann Am Thorac Soc. 2021. PMID: 32970455
-
Patient reported outcome measures (PROMs) in sarcoidosis.Sarcoidosis Vasc Diffuse Lung Dis. 2017;34(1):2-17. doi: 10.36141/svdld.v34i1.5760. Epub 2017 Apr 28. Sarcoidosis Vasc Diffuse Lung Dis. 2017. PMID: 32476819 Free PMC article. Review.
-
The Symptoms of Pulmonary Sarcoidosis.J Clin Med. 2023 Sep 20;12(18):6088. doi: 10.3390/jcm12186088. J Clin Med. 2023. PMID: 37763028 Free PMC article. Review.
Cited by
-
Contemporary Diagnostics of Cardiac Sarcoidosis: The Importance of Multimodality Imaging.Diagnostics (Basel). 2024 Aug 26;14(17):1865. doi: 10.3390/diagnostics14171865. Diagnostics (Basel). 2024. PMID: 39272650 Free PMC article. Review.
-
Vitamin D deficiency, fatigue, and persistent cough as independent predictors of depressive symptoms in sarcoidosis patients.J Med Biochem. 2025 Jun 13;44(3):495-506. doi: 10.5937/jomb0-54015. J Med Biochem. 2025. PMID: 40821627 Free PMC article.
References
-
- Hunninghake GW, Costabel U, Ando M et al.. ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16:149–73. - PubMed
-
- Drent M, Lower E. De Vries J. Sarcoidosis-associated fatigue. Eur Respir J 2012; 40:255–263. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous